Skip to main content

Morosini Deborah's Form 4 filing

Prelude Therapeutics Inc (PRLD) · filed Dec 17, 2021

Accession no.
0001209191-21-070352
Filed
Dec 17, 2021
Trade date
Dec 15, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $373.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Morosini DeborahCIK 0001824625Officer (EVP, Chief of Clinical Affairs)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 15, 2021Common StockMOption exerciseAcquired+3,016$1.89+$5,700.243,460Direct
Dec 15, 2021Common StockMOption exerciseAcquired+25,735$12.85+$330,694.7529,195Direct
Dec 15, 2021Common StockSSaleDisposed−28,751$13.00−$373,763444Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 15, 2021Common StockMOption exerciseDisposed−3,016$0.00$01,307Direct
Dec 15, 2021Common StockMOption exerciseDisposed−24,853$0.00$074,575Direct
Dec 15, 2021Common StockMOption exerciseDisposed−882$0.00$0195,163Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)